Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Lung Neoplasms 1Cachexia 1

Interventions

pembrolizumab 91Blood Specimen Collection 43Cyclophosphamide 37Nivolumab 36Bevacizumab 36Standard of Care 32Carboplatin 31Surveys and Questionnaires 29Paclitaxel 27atezolizumab 25Exercise 25Pemetrexed 24Gemcitabine 24Cisplatin 23Fluorouracil 22Radiotherapy 20Leucovorin 20Dexamethasone 20Oxaliplatin 19Docetaxel 19Rituximab 16Irinotecan 16Cetuximab 16dostarlimab 15Drug Therapy 15Doxorubicin 15Biopsy 15130-nm albumin-bound paclitaxel 15Prednisone 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Retrospective Studies × 1 year × Clear all
NCT03568019 2026-04-21

PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors

University of Texas Southwestern Medical Center

Active not recruiting
10,000 enrolled

Cachexia, Neoplasms

NCT06270602 2025-12-22

The ONCOCAMP Study

National Cancer Institute, Naples

Recruiting
15,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡